Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Lilly said it doesn't believe patients should be exposed to "the risks in taking untested, unapproved knockoffs." "FDA has rightly and repeatedly expressed concerns with unapproved GLP-1 drugs used for weight loss, and that such drugs are risky for patients, as unapproved versions do not undergo FDAs review for safety, effectiveness and quality before they are marketed," the company said in a statement to FOX Business
But averages conceal an enormous range
Researchers should exercise caution and adhere to all regulatory guidelines when handling and studying these compounds
Have a significant amount of weight to lose: Individuals with a higher body mass index (BMI) may see more pronounced results from weight loss injections
First, these data reflect prescribing patterns only through July 2025 and may not capture whether the trends persist over a longer period following the formulary change
US$ 22.24
US$ 29.92
US$ 24.64
US$ 21.58
US$ 23.69
US$ 29.93
US$ 29.26
